SCHEMBL23451697

SCHEMBL23451697

[CH2]C(CCCN(CC)CC)CCCN(CC)CC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.42
PLA2G1B P04054 1/20 0.35
PLA2G2A P14555 1/20 0.35
CACNA2D1 P54289 10/20 0.33
SLC2A1 P11166 1/20 0.32
MEN1 O00255 1/20 0.32
POLB P06746 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23451616 0.97 SIGMAR1 (0.41) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL23451750 0.97 SIGMAR1 (0.41) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL28817801 0.80 PLA2G1B (0.42) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL27681136 0.80 SIGMAR1 (0.39) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL441038 0.76 SIGMAR1 (0.43) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL23451784 0.74 SIGMAR1 (0.42) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL1147030 0.74 SIGMAR1 (0.42) SIGMAR1PLA2G1BPLA2G2ACACNA2D1NPSR1
SCHEMBL5948920 0.74 SIGMAR1 (0.42) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL8620339 0.74 SIGMAR1 (0.42) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1
SCHEMBL1147313 0.74 PLA2G1B (0.56) SIGMAR1PLA2G1BPLA2G2ACACNA2D1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210175073-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175073-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE NOS1, NOS2, CHRM1 SIGMAR1 67/4885PLA2G1B 2893/4885PLA2G2A 3055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.